semaglutide compounding fda enforcement news issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA is moving to restrict

As a Patient Founder, you're not just getting medical careyou're receiving an exclusive, personalized blueprint to reverse aging at a cellular level

Focus on protein and hydration Making healthy lifestyle changes like eating more protein and drinking more water supports skin health from the inside out

In the New England Journal of Medicine a double-blind randomized trial of 156 participants with early Parkinsons disease were assigned to lixisenatide or placebo

Afamelanotide received EMA approval in December 2014 and FDA approval on 8 October 2019 , in both cases specifically to increase pain-free light exposure in adults with a history of phototoxic reactions from erythropoietic protoporphyria